An integrative systems biology approach to understanding pulmonary diseases.
暂无分享,去创建一个
Charles Auffray | Peter J Sterk | Ratko Djukanovic | Kian Fan Chung | Ian M Adcock | C. Auffray | I. Adcock | K. Chung | P. Sterk | R. Djukanović | C. Pison | Christophe Pison | K. Chung
[1] R. A. Killington,et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation , 2008, Nature Medicine.
[2] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[3] I. Adcock,et al. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma , 2008, Thorax.
[4] Mike Thomas,et al. Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.
[5] I. Adcock,et al. Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.
[6] W. Busse,et al. Severe asthma in adults: what are the important questions? , 2007, The Journal of allergy and clinical immunology.
[7] D. Postma,et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. , 1999, The European respiratory journal.
[8] I. Pavord,et al. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids , 2002, Thorax.
[9] Jason A. Papin,et al. Comparison of network-based pathway analysis methods. , 2004, Trends in biotechnology.
[10] Peter Hunter,et al. A strategy for integrative computational physiology. , 2005, Physiology.
[11] G. Anderson,et al. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease , 2008, The Lancet.
[12] R. Stoughton. Applications of DNA microarrays in biology. , 2005, Annual review of biochemistry.
[13] D. Postma,et al. Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. , 2005, The Journal of allergy and clinical immunology.
[14] Barmak Modrek,et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.
[15] Charles Auffray,et al. 'The 39 steps' in gene expression profiling: critical issues and proposed best practices for microarray experiments. , 2005, Drug discovery today.
[16] A. Brazma,et al. Standards for systems biology , 2006, Nature Reviews Genetics.
[17] I. Pavord,et al. A new perspective on concepts of asthma severity and control , 2008, European Respiratory Journal.
[18] L. Hood,et al. Systems medicine: the future of medical genomics and healthcare , 2009, Genome Medicine.
[19] Rolf Apweiler,et al. Linking publication, gene and protein data , 2006, Nature Cell Biology.
[20] E. D. de KLERK,et al. Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. , 2001, American journal of respiratory and critical care medicine.
[21] Michael E Phelps,et al. Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.
[22] Xianlin Han. An update on lipidomics: progress and application in biomarker and drug development. , 2007, Current opinion in molecular therapeutics.
[23] K. Rabe,et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma , 2008, European Respiratory Journal.
[24] D. Corry,et al. Discovery of novel markers in allergic lung inflammation through proteomic-based technologies , 2008, Expert review of proteomics.
[25] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[26] P. Barnes. New therapies for asthma. , 2006, Trends in molecular medicine.
[27] Bernhard O Palsson,et al. Hierarchical thinking in network biology: the unbiased modularization of biochemical networks. , 2004, Trends in biochemical sciences.
[28] S. Wenzel. Asthma: defining of the persistent adult phenotypes , 2006, The Lancet.
[29] R. Aebersold,et al. Advances in proteomic workflows for systems biology. , 2007, Current opinion in biotechnology.
[30] David J. Reiss,et al. Integrated biclustering of heterogeneous genome-wide datasets for the inference of global regulatory networks , 2006, BMC Bioinformatics.
[31] Thomas D. Schmittgen,et al. Integrating the MicroRNome into the study of lung disease. , 2009, American journal of respiratory and critical care medicine.
[32] P. Sly,et al. Animal models of asthma , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[33] A. Zwinderman,et al. Risk factors of frequent exacerbations in difficult-to-treat asthma , 2005, European Respiratory Journal.
[34] Edgar Erdfelder,et al. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.
[35] T. Hudson,et al. Functional classes of bronchial mucosa genes that are differentially expressed in asthma , 2004, BMC Genomics.
[36] N. Hanania. Targeting airway inflammation in asthma: current and future therapies. , 2008, Chest.
[37] Parameswaran Nair,et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.
[38] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[39] D. Curran‐Everett,et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.
[40] D. Postma,et al. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma , 2003, European Respiratory Journal.
[41] Ana Sousa,et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.
[42] A. Fernie,et al. Metabolite profiling: from diagnostics to systems biology , 2004, Nature Reviews Molecular Cell Biology.
[43] Mario Castro,et al. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. , 2008, The Journal of allergy and clinical immunology.
[44] Richard Simon,et al. Roadmap for developing and validating therapeutically relevant genomic classifiers. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] Peter J Sterk,et al. An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.
[46] Charles Auffray,et al. From functional genomics to systems biology: concepts and practices. , 2003, Comptes rendus biologies.
[47] D. Vercelli,et al. Discovering susceptibility genes for asthma and allergy , 2008, Nature Reviews Immunology.
[48] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[49] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[50] J. Bousquet,et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. , 2008, The New England journal of medicine.
[51] Leroy Hood,et al. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.